PHARMACYTE BIOTECH, INC. Assets, Noncurrent
PHARMACYTE BIOTECH, INC. (PMCB) had Assets, Noncurrent of $5.74 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2026-09-14
- 2026-07-31: Assets, Noncurrent $5.74M.
- 2026-04-30: Assets, Noncurrent $9.33M.
- 2026-01-31: Assets, Noncurrent $35.18M.
- 2025-10-31: Assets, Noncurrent $32.95M.
| Period end | Assets, Noncurrent |
|---|---|
| 2026-07-31 | $5.74M 10-Q · filed 2026-09-14 |
| 2026-04-30 | $9.33M 10-Q · filed 2026-09-14 |
| 2026-01-31 | $35.18M 10-Q · filed 2026-03-17 |
| 2025-10-31 | $32.95M 10-Q · filed 2025-12-18 |
| 2025-07-31 | $26.00M 10-Q · filed 2025-09-15 |
| 2025-04-30 | $32.79M 10-K · filed 2026-07-29 |
| 2025-01-31 | $26.87M 10-Q · filed 2025-03-17 |
| 2024-10-31 | $33.77M 10-Q · filed 2024-12-13 |
| 2024-07-31 | $37.32M 10-Q · filed 2024-09-17 |
| 2024-04-30 | $9.46M 10-K · filed 2025-08-11 |
| 2024-01-31 | $9.85M 10-Q · filed 2024-03-18 |
| 2023-10-31 | $5.13M 10-Q · filed 2023-12-15 |
| 2023-07-31 | $5.13M 10-Q · filed 2023-09-18 |
| 2023-04-30 | $5.13M 10-K · filed 2024-08-13 |
| 2023-01-31 | $5.13M 10-Q · filed 2023-03-16 |
| 2022-10-31 | $5.13M 10-Q · filed 2022-12-14 |
| 2022-07-31 | $5.13M 10-Q · filed 2022-09-14 |
| 2022-04-30 | $5.13M 10-K · filed 2023-07-31 |
| 2022-01-31 | $5.13M 10-Q · filed 2022-03-15 |
| 2021-10-31 | $5.13M 10-Q · filed 2021-12-14 |
| 2021-07-31 | $5.13M 10-Q · filed 2021-09-14 |
| 2021-04-30 | $5.13M 10-K · filed 2022-07-28 |
| 2021-01-31 | $5.13M 10-Q · filed 2021-03-12 |
| 2020-10-31 | $5.13M 10-Q · filed 2020-12-11 |
| 2020-07-31 | $5.13M 10-Q · filed 2020-09-11 |
| 2020-04-30 | $5.13M 10-K · filed 2021-08-10 |
| 2020-01-31 | $5.13M 10-Q · filed 2020-03-13 |
| 2019-10-31 | $5.13M 10-Q · filed 2019-12-23 |
| 2019-07-31 | $5.13M 10-Q · filed 2019-09-13 |
| 2019-04-30 | $5.13M 10-K · filed 2020-08-13 |
| 2019-01-31 | $5.13M 10-Q · filed 2019-03-14 |
| 2018-10-31 | $5.13M 10-Q · filed 2018-12-14 |
| 2018-07-31 | $5.13M 10-Q · filed 2018-09-12 |
| 2018-04-30 | $5.13M 10-K · filed 2019-08-13 |
| 2018-01-31 | $5.13M 10-Q · filed 2018-03-19 |
| 2017-10-31 | $5.13M 10-Q · filed 2017-12-14 |
| 2017-07-31 | $5.13M 10-Q · filed 2017-09-13 |
| 2017-04-30 | $5.13M 10-K · filed 2018-07-20 |
| 2017-01-31 | $5.13M 10-Q · filed 2017-03-13 |
| 2016-10-31 | $5.13M 10-Q · filed 2016-12-02 |
| 2016-07-31 | $5.13M 10-Q · filed 2016-09-06 |
| 2016-04-30 | $5.13M 10-K · filed 2017-07-27 |
| 2016-01-31 | $5.13M 10-Q · filed 2016-03-08 |
| 2015-10-31 | $5.13M 10-Q/A · filed 2016-01-19 |
| 2015-07-31 | $5.13M 10-Q/A · filed 2016-01-19 |
| 2015-04-30 | $5.13M 10-K · filed 2016-07-29 |
| 2014-04-30 | $5.13M 10-K/A · filed 2016-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |